WEB™ Intrasaccular Embolization
WEBCAST 2: Extension of WEBCAST study
"WEBCAST 2 confirms the high safety and efficacy of WEB aneurysm treatment demonstrated in the WEBCAST and French Observatory studies."
- Patients
55
- Countries
France, Hungary, Germany, Belgium, Denmark
- Clinical Centers
10
- Design
Single arm prospective
- Scope
Patients 18-75 y.o., with wide neck bifurcation intracranial aneurysms ruptured or unruptured, H&H<4, treatable with WEB only
- Purpose
Assessment of safety, efficacy and technical success of WEB to 5 years, including single layer device.
Endpoints
Durability of occlusion at 6 months defined as complete occlusion or stable neck remnant with no worsening from baseline and no retreatment performed or planned (assessed by Corelb)
Efficacy results
At 6 months:
Complete occlusion: 57.1% / Adequate occlusion: 79.6%
At 12 months:
Complete occlusion: 54.0% / Adequate occlusion: 80.0%
Safety results
At 30 days:
Morbidity: 3.6%
Mortality:0%
At 12 months:
Morbidity: 3.9%
Mortality:2%
Study publications
LINK TO STUDY PAGE ClinicalTrials.gov ID NCT01778322
Please refer to IFU for the full list of risks, contraindications, warnings, and precautions.
Explore more studies
WEB™ Intrasaccular Embolization
French Observatory: WEB™ French Observatory of the WEB Aneurysm Embolization System
Request more information
By submitting, you agree to our privacy policy.